Antibacterial drug management: challenges, strategies and future perspectives

Summary: As antibacterial resistance increases, the management of antibacterial drugs becomes an important issue in global public health.

The purpose of this paper is to explore current challenges in the management of antibacterial drugs, to analyse effective management strategies and to look forward to future directions. Through literature reviews and case studies, a series of targeted management measures have been proposed and discussions have been held on how to implement them at different levels.

Keywords: antibacterial drug resistance; drug management; public health; strategy

Introduction

Antibacterial resistance is one of the major health threats facing the world. As a result of overuse and misuse of antibacterial drugs, bacteria have gradually developed resistance, making it difficult to control many infections that were easily treated. Effective management of antibacterial drugs is therefore essential to control the development of resistance.

Overuse of antibacterial drugs: In clinical practice, due to the preferences of doctors and patients, antibacterial drugs are often overused, especially when treating minor or viral infections. 2. Inappropriate prescription: The lack of adequate knowledge of antibacterial drugs among some health workers leads to inappropriate prescription and dose use. 3. Patients ‘ dependence is poor: their failure to complete the whole course of treatment as prescribed by the doctor has resulted in the complete elimination of the bacteria and increased the risk of drug resistance. 4. Insufficient public education: insufficient public awareness of anti-bacterial drug resistance and lack of knowledge of the rational use of antibacterial drugs. 5. Poor regulatory systems: In some regions, inadequate regulatory systems for anti-bacterial drugs have led to the circulation of illegal and hypocritical drugs.

1. Strengthening education on the rational use of antibacterial drugs: raising awareness among health-care workers and the public about the rational use of antibacterial drugs through professional training and public education. 2. Develop and implement anti-bacterial drug management policies, including the establishment of guidelines for the use of anti-bacterial drugs, the monitoring of the use of anti-bacterial drugs and the restriction of the use of certain high-risk drugs. 3. Enhanced regulation and quality control: ensuring the quality of antibacterial drugs in circulation in the market and combating illegal and fraudulent drugs. 4. Promotion of rapid diagnostic techniques: Accurate identification of types of infection through rapid diagnostic techniques to avoid unnecessary use of antibacterial drugs. 5. Implementation of antibacterial drug use review and feedback mechanisms: periodic review of antibacterial drug use and provision of feedback to medical workers to improve prescription behaviour.

1. Technological innovations: Optimizing the use and management of antibacterial drugs using technologies such as artificial intelligence and big data. 2. International cooperation: strengthening international cooperation and information-sharing in the management of anti-bacterial drugs to jointly address drug resistance challenges. Ongoing monitoring and research: Establish a long-term antibacterial resistance monitoring system, support relevant research and provide a scientific basis for policy formulation.

Effective management of antibacterial drugs is essential to control drug resistance. The use of antibacterial drugs can be significantly improved and the development of resistance can be mitigated by a combination of education, policy development, regulation and technical applications. In the future, global cooperation and sustained efforts are needed to ensure the long-term effectiveness of antibacterial drugs.

References:

World Health Organization.

Centers for Disease Control and Prevention. Antibiotic access treaties in the United States, 2019.

[3] Laxminarayan R, et al. Antibiotic response-the need for global solutions. Lancet Infect Dis. 2013; 13(12): 1057-1098.

[4] Spellberg B, et al., The situation of antitics and respect: a situation to be considered by John Bartlett.